QA: Longeveron Inc in us_pharma/2023

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001721484_2024_Longeveron_Inc.pdf

Logs

warning The stock price does not exist industry.us_generic {}
warning Missing logo subcommand.report {}

Graph

Absolute values for 0001721484, Longeveron Inc

  xvar xval
0 AssetsCurrent 5,848,000
1 IntangibleAssetsNetIncludingGoodwill 2,287,000
2 PropertyPlantAndEquipmentNet 2,529,000
3 remainder_Assets 1,414,000
4 LiabilitiesCurrent 3,889,000
5 LiabilitiesNoncurrent 1,448,000
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 488,000
8 SellingGeneralAndAdministrativeExpense 11,401,000
9 ResearchAndDevelopmentExpense 9,066,000
10 remainder_Expenses 783,000
11 remainder_Revenues 709,000
12 remainder_NetIncome -384,000
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 12,078,000
1 Liabilities 5,337,000
2 Expenses 21,738,000
3 Revenues 709,000
4 StockholdersEquity 6,741,000
5 NetIncome -21,413,000
6 ComprehensiveNetIncome -21,413,000
7 BaseVar 20,123,000
8 EconomicCapitalRatiobeforeLimitedLiability -0.771
9 EconomicCapitalRatio 1.34

Edgar->Model Mapping

Feature Distribution

Change over Time